Figures & data
Figure 1 Nanoformulations in medicinal products.
Notes: Copyright ©2014. Dove Medical Press. Reproduced from Hafner A, Lovric J, Lakos GP, Pepic I. Nanotherapeutics in the EU: an overview on current state and future directions. Int J Nanomedicine. 2014;9:1005–1023.Citation11
Abbreviation: PEG, polyethylene glycol.
![Figure 1 Nanoformulations in medicinal products.Notes: Copyright ©2014. Dove Medical Press. Reproduced from Hafner A, Lovric J, Lakos GP, Pepic I. Nanotherapeutics in the EU: an overview on current state and future directions. Int J Nanomedicine. 2014;9:1005–1023.Citation11Abbreviation: PEG, polyethylene glycol.](/cms/asset/9fe2c492-e012-4d7e-aa3a-a71c3bfce902/dijn_a_102385_f0001_c.jpg)
Table 1 Examples of immunotoxic effects reported after in vitro or in vivo testing of nanomaterials
Figure 2 Illustration of the three pathways of complement activation-related pseudoallergy induction.
Notes: Republished with permission of ELSEVIER BV from Interactions of nanomaterials and biological systems: implications to personalized nanomedicine. Zhang XQ, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. 2012;64(13); permission conveyed through Copyright Clearance Center, Inc.Citation105
Abbreviations: Ig, immunoglobulin; PEG, polyethylene glycol; SWCNT, single-walled carbon nanotubes; MBL, mannose binding lectin; MASPs, mannose-binding lectin-associated serin protease.
![Figure 2 Illustration of the three pathways of complement activation-related pseudoallergy induction.Notes: Republished with permission of ELSEVIER BV from Interactions of nanomaterials and biological systems: implications to personalized nanomedicine. Zhang XQ, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. 2012;64(13); permission conveyed through Copyright Clearance Center, Inc.Citation105Abbreviations: Ig, immunoglobulin; PEG, polyethylene glycol; SWCNT, single-walled carbon nanotubes; MBL, mannose binding lectin; MASPs, mannose-binding lectin-associated serin protease.](/cms/asset/c47dadaa-cf21-4e76-a592-a0972179296e/dijn_a_102385_f0002_c.jpg)
Table 2 Summary of the standard toxicity tests and the additional immunotoxicity assays recommended by the harmonized ICH S8 guideline
Table 3 Examples of immunotoxic effects of NMs or NMPs, and whether the testing methods included in the ICH S8 guideline are expected to detect the immunotoxic effects reported